Outlook Therapeutics director Ghiath Sukhtian buys $2.5m in shares Aug 15, 2026 Outlook Therapeutics director Ghiath Sukhtian buys $2.5m in shares
Bosses are firing Gen Z grads just months after hiring them—here’s what they say needs to change wealthreport Sep 26, 2024
This 6.5%-Yielding Stock Has Paid Dividends for Nearly 70 Years and Has Plenty of Fuel to Continue Paying Them wealthreport Sep 26, 2024